Tetra Bio-Pharma Joins BIOTECanada
November 13, 2019 08:00 ET
|
Tetra Bio-Pharma
OTTAWA, Nov. 13, 2019 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc. (“Tetra” or “TBP”) is pleased to announce that the Corporation has become a member of BIOTECanada, a national industry association...
Tetra Bio-Pharma Confirms Regulatory Strategy of Lead Product CAUMZ™ and Strengthens Management Team
November 11, 2019 08:00 ET
|
Tetra Bio-Pharma
OTTAWA, Nov. 11, 2019 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc., (TSX-V) (OTCQB: TBPMF), a leader in drug discovery and development for cannabinoid-based therapeutics, today confirmed its regulatory...
Tetra Bio-Pharma Provides Management Update on Commercializing its Inhalation Drug Caumz®
October 21, 2019 08:00 ET
|
Tetra Bio-Pharma
OTTAWA, Oct. 21, 2019 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc. (“Tetra” or “TBP”) today provides an update on its initiatives to bring its Caumz® (PPP011) inhalation drug product to the market. ...
Tetra Bio-Pharma Provides Regulatory Update for Its CAUMZ(TM) Kit
October 03, 2019 08:30 ET
|
Tetra Bio-Pharma
U.S. Food and Drug Administration (FDA) allows evaluation of CAUMZ Kit as a combination drug/device product, providing clarity on regulatory approval pathwayThis is a first step in the regulatory...
Tetra Bio-Pharma Announces Joint Venture with Thorne and Onegevity Health to Form CB2 Therapeutics
August 21, 2019 06:30 ET
|
Tetra Bio-Pharma
OTTAWA, Aug. 21, 2019 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc., (TSX-V: TBP) (OTCQB: TBPMF), a leader in drug discovery and development for cannabinoid-based therapeutics, today announced it has...
Tetra Bio-Pharma Engages LifeSci Advisors and LifeSci Public Relations as Strategic Partners
August 12, 2019 16:05 ET
|
Tetra Bio-Pharma
ORLEANS, Ontario, Aug. 12, 2019 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc., a leader in drug discovery and development for cannabinoid-based therapeutics, announced today the company has engaged...
Dr. Guy Chamberland returns to “Stock Day” Podcast with Everett Jolly to discuss Tetra-Biopharma
May 09, 2018 08:30 ET
|
Tetra Bio-Pharma
PHOENIX, May 09, 2018 (GLOBE NEWSWIRE) -- Dr. Guy Chamberland, Co-Founder, Chief Scientific Officer and Interim-CEO of Tetra-Biopharma Inc. (OTCQB:TBPMF) (TSX-V:TBP) (“the Company”) joined Everett...